Niemi, Riikka Johanna
Braicu, Elena Ioana
Kulbe, Hagen
Koistinen, Kaisa Maria
Sehouli, Jalid
Puistola, Ulla
Mäenpää, Johanna Unelma
Hilvo, Mika http://orcid.org/0000-0003-0663-5843
Article History
Received: 26 February 2018
Revised: 20 August 2018
Accepted: 31 August 2018
First Online: 8 October 2018
Ethics approval
: The investigation was approved by the local Ethical Committees of Charité, Oulu and Tampere University Hospitals. The study was performed in accordance with the Declaration of Helsinki
: The data sets generated during and/or analysed during the current study are available for non-commercial use from the corresponding author on reasonable request.
: M.H. and K.M.K. are employed by Zora Biosciences Oy, which holds patent disclosures for diagnostic tests of ovarian cancer using small molecules, including lipids. J.U.M. reports grants and personal fees from Roche, AstraZeneca, Tesaro, SOBI and Clovis, outside the submitted work. R.J.N., E.I.B., H.K., J.S. and U.P. declare no competing interests.
: No external funding was used for conducting this study.
: All patients gave their informed consent to the study.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).